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Background: Right heart catheterization (RHC) is the gold-standard in the diagnosis of pulmonary hyper-
tension (PH) but at the cost of procedure-related complications. We sought to determine the comparative
accuracy of RHC versus non-invasive imaging techniques such as computed tomography (CT), magnetic
resonance imaging (MRI), and transthoracic echocardiography (TTE).
Methods: Pulmonary hypertension was defined as a mean pulmonary artery pressure (mPAP)
of>20 mmHg. Multiple databases were queried for relevant articles. Raw data were pooled using a bivari-
ate model to calculate the measures of diagnostic accuracy and to estimate Hierarchical Summary
Receiver Operating Characteristic (HSROC) on Stata 13.
Results: A total of 51 studies with a total patient population of 3947 were selected. The pooled sensitivity
and specificity of MRI for diagnosing PH was 0.92(95% confidence interval (CI) 0.88–0.96) and 0.86 (95%
CI, 0.77–0.95), respectively. The net sensitivities for CT scan and TTE were 0.79 (95% CI 0.72–0.89) and
0.85 (95% CI 0.83–0.91), respectively. The overall specificity was 0.82 (0.76–0.92) for the CT scan and
0.71 (95% CI 0.61–0.84) for TTE. The diagnostic odds ratio (DOR) for MRI was 124 (95% CI 36–433) com-
pared to 30 (95% CI 11–78) and 24 (95% 11–38) for CT scan and TTE, respectively. Chi-squared (x2) test
showed moderate heterogeneity on the test for equality of sensitivities and specificities.
Conclusions: MRI has the highest sensitivity and specificity compared to CT and TTE. MRI can potentially
serve as a surrogate technique to RHC for the diagnosis of PH.
 2020 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
RHC is a gold standard for the diagnosis of pH by measuring
mean pulmonary arterial systolic pressure (mPASP) [1]. Although
RHC has the highest diagnostic accuracy, it comes at the cost of
invasive procedure, catheter-related complications, and occasion-
ally risk of data misinterpretation due to errors in catheter place-
ment [2]. Traditionally, less invasive techniques, including TTE,
have been an area of interest for diagnosis of PH [3].
TTE is extensively used for the screening and diagnosis of PH. It
might allow for accurate estimates of mPASP, but with moderate
precision, which makes it an appropriate approach for population
studies rather than for individual patients [4]. Recently, CT and
MRI has been gaining traction as a non-invasive alternative to
RHC. The study by Shen et al. reported that CT scan have a sensitiv-
ity and specificity of 0.79–0.83 and 0.74–0.81, respectively [5,6].
https://doi.org/10.1016/j.ijcha.2020.100568
2352-9067/ 2020 The Author(s). Published by Elsevier B.V.
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Despite the recent advances, the comparative accuracy of less inva-




A literature search for relevant articles was performed from
inception to April 15, 2020, using PubMed, Ovid, Embase, clinical-
trials.gov, and Cochrane databases. There was no language or time
restriction placed. The search strategies included various combina-
tions of keywords and medical subject headings (MeSH) to gener-
ate four subsets of citations: magnetic resonance imaging (MRI),
computed tomography (CT), transthoracic echocardiography
(TTE) and pulmonary hypertension (PH). The terms from all sub-
sets were combined in 1:1 combination using Boolean operators,
and results from all possible combinations were downloaded into
an EndNote library. Based on our research question, articles from
the reference lists relevant to the clinical question were also
screened by an independent author.
2.2. Selection criteria and study collection
All observational (retrospective/prospective) studies and ran-
domized control trials (RCT) were evaluated. Articles comparing
the diagnostic accuracy of MRI, CT, or TEE with RHC were included
in the study. Inclusion criteria for study articles were as follows:
(1) original articles published in English; (2) it included subjects
who had mPAP, mPAD or PA:A ratio measurement for detection
of PH; (3) surrogate markers for PH such as RV strain or tricuspid
regurgitation was assessed; (4) patients were in stable condition;
and (5) articles reported sufficient raw data to calculate sensitivity
and specificity. (6) The most common criteria of TTE used to define
PH included pulmonary artery systolic and mean pressure, tricus-
pid regurgitation, right ventricular systolic pressure, right ventric-
ular diameter, and right ventricular free wall strain. CT and MRI
also used interventricular septum curvature, ratio of interventricu-
Fig. 1. Summary and Detailed Quality assessment of the included studies.
Fig. 2. PRISMA flow diagram of the included studies.
Fig. 1 (continued)
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lar septum curvature and left ventricular free wall, pulmonary
artery pulsatility, pulmonary artery distensibility, ventricular mass
index, pulmonary artery stiffness, and dilation of the main pul-
monary artery as diagnostic criterias. Papers with insufficient data,
review articles, case reports, editorials, and conference papers
were excluded. Pulmonary hypertension was defined as a mean
pulmonary artery pressure (mPAP) of>20 mmHg.
2.3. Data extractions
Five authors independently screened titles and abstracts of all
the articles for relevance, and the sixth author selected articles
which met the inclusion criteria. Full text articles that were poten-
tially relevant to the study was screened by the seventh author to
confirm eligibility. Baseline characteristics of the included popula-
tion were reviewed, and data were collected for quality assessment
to ensure study cohorts were statistically comparable. Data was
finally extracted into the combined Excel sheet. Disagreements
were resolved by mutual consensus and after a detailed group
discussion.
2.4. Data and quality analysis
Raw data regarding the true and false positives and true and
false negatives of each included study was obtained, and the com-
bined measures of test accuracy [i.e., sensitivity, specificity, and
diagnostic odds ratio (DOR)] for all non-invasive imaging modali-
ties were calculated, keeping RHC a standard. A bivariate model
was obtained from data fitting. The parameters from the bivariate
model were transformed into Hierarchical Summary Receiver
Operating Characteristic (HSROC) estimates. The area under the
summary HSROC curve (AUC) was calculated to reveal the proba-
bility of accurately ranked diagnostic test values for a random pair
of subjects (one with disease and one without disease). Chi-
squared (x2) tests were conducted to evaluate the heterogeneity
of sensitivities and specificities among all studies. Subgroup analy-
sis based on the diagnostic threshold cutoff points of the index test
was done to explore the potential heterogeneity factors using
meta-regression analysis. Quality of the included studies was
assessed for the potential bias and applicability concerns using
the Quality Assessment of Diagnostic Accuracy Studies (QUADAS-
2) standard questionnaire. The statistical analysis was performed
using the diagnostic accuracy statistical model on the Stata and R
mad package.
2.5. Quality of included studies
Based on the QUADAS-2 tool, the overall risk of bias and appli-
cability concerns based on patient selection, index and reference
standard was low. (Fig. 1) In the study by Cotton et al., the patient
selection bias was of unclear concern. The risk of bias associated
Fig. 3. Forest plot showing the individual and pooled sensitivity and specificity of MRI.
Fig. 4. ROC demonstrating a higher sensitivity and specificity for MRI compared to
RHC.
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with flow and timing was of unclear concern due to inadequate
reporting across most studies. (Fig. 1) The optimal timing between
the index test (TTE, CT or MRI) and the reference standard (RHC)
was uncertain across most articles. The impact of inadequate
reporting on the interpretation of their respective results is
uncertain.
3. Results
3.1. Search results and study selection
The initial search on included databases revealed 15,741 arti-
cles. After the removal of irrelevant and duplicate items, only
269 articles were deemed relevant for full-text review. We further
excluded 219 articles based on our selection criteria; only 51 stud-
ies were included for final analysis. The Prisma flow diagram is
shown in Fig. 2.
A total of 51 studies comprising 3947 patients, were included in
the study. The mean age of the included patients was 56 years,
with an average male population of 46%. The detailed characteris-
tics of the included studies are summarized in supplementary
table 1.
3.2. Pooled sensitivity and specificity Results:
Compared to RHC, the pooled sensitivity and specificity of MRI
for diagnosing PH was 0.92 (95% confidence interval (CI) 0.88–
0.96) and 0.86 (95% CI, 0.77–0.95). (Figs. 3, 4) The sensitivity and
Fig. 5. Forest plot showing the individual and pooled sensitivity and specificity of CT.
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specificity of CT scan was 0.79 (95% CI, 0.72–0.89) and 0.82 (95% CI,
0.76–0.92) (Figs. 5, 6). TTE showed a sensitivity and specificity of
0.85 (95% CI, 0.83–0.91) and 0.71 (95% CI, 0.61–0.84) (Figs. 7, 8).
3.3. Subgroup Analysis:
A subgroup analysis based on the matched inclusion criteria
and diagnostic parameters of PH was also performed. The subgroup
analysis mirrored the overall findings of the pooled analysis with a
few exceptions. In contrast to the pooled results of TTE, the sensi-
tivity and specificity values were 0.92 and 0.45, when RV free wall
strain was used as a diagnostic criteria. On the other hand, the sen-
sitivity and specificity of different parameters used for defining PH
based on CT scan ranged from (0.65–0.84) and (0.78–0.90), respec-
tively, which were comparable to the corresponding pooled
results. The detailed subgroup diagnostic accuracy values are
shown in Table 1.
3.4. Chi-squared testing results
The heterogeneity among the outcomes of the included studies
was moderate through all comparisons. The Chi-squared (x2) test
for the sensitivity and specificity of MRI was 13 and 38, with a
p=<0.1. The x2-test for the sensitivity and specificity of CT was
131 and 73 with a p=< 0.1 while it was 47 and 162 (p=< 0.1),
respectively.
3.5. Likelihood and diagnostic odds ratio results
The positive likelihood ratios (PLR) for MRI, CT and TTE were
8.7 ± 3.5 (95% CI 3.93–19.27), 6.0 ± 0.8 (95% CI 3.3–10.6) and
3.4 ± 0.8 (95% CI 2.23–5.31) respectively. The negative likelihood
ratios (NLR) for MRI, CT and TTE was 0.069 ± 0.2 (95% CI 0.035–
0.13), 0.19 ± 0.01 (0.11–0.33) and 0.15 ± 0.03 (95% CI 0.11–0.22)
respectively. The diagnostic odds ratio (DOR) for MRI was highest
at 124 (95% CI, 36–433) compared to 30 (95% CI, 11–78) and 24
(95% CI, 11–38) for CT and TTE, respectively
4. Discussion
To the best of our knowledge, this is the first meta-analysis
comparing multiple noninvasive modalities with RHC for the diag-
nosis of pulmonary hypertension. This is also the most updated
meta-analysis with the largest number of studies and the largest
sample size in each noninvasive diagnostic test category. Our
results revealed that all three noninvasive imaging modalities
might have a predictive value for the diagnosis of pulmonary
hypertension (PH). On pooled analysis, MRI demonstrated the
greatest diagnostic accuracy as signified by a large area under
the curve on Receiver Operating Characteristic (ROC). The sensitiv-
ity and specificity of TTE and CT scan were also comparable to right
heart catheterization (RHC), however, was relatively lower com-
pared to MRI. Chi-squared testing for the evaluation of heterogene-
ity resulted in moderate heterogeneity, inferring that the results
demonstrated likely reflect the true ability of other imaging modal-
ities in the prediction of pH as compared to RHC. Though all three
imaging modalities demonstrated a positive and significant rela-
tion to RHC, the likelihood ratios (LR) and diagnostic odds ratio
(DOR) substantially favored MRI than CT and TTE in comparison
to RHC.
PH results in dilatation of the right-sided heart chambers and
subsequent tricuspid regurgitation [7]. These two phenomena play
a critical role in the estimation of PH via noninvasive tests [8]. A
mean pulmonary arterial pressure (PAP > 20 mmHg) is considered
a diagnostic of PH when measured at rest in the supine position.
However, a variety of parameters and cutoff were found to be sug-
gestive of PH, explaining the heterogeneity among the included
studies [9]. The suggestive findings for PH on MRI included ventric-
ular mass index (VMI) and right atrial (RA) pulsatility. VMI is cal-
culated by dividing the right ventricular mass by that of the left
ventricle mass (VMI = RVM/LVM) [10]. The reported sensitivity
and specificity of VMI is 84% and 82%, respectively [11]. A study
by Seba et al. found VMI assessment of PH by MRI has a higher
accuracy as compared to pressure assessment of TTE [12]. A meta-
analysis by Wang et al. also used VMI as a measure and found to
have high pooled sensitivity (84%) and specificity (82%)[11]. Our
meta-analysis included 6 studies to assess the diagnostic accuracy
of MRI using both RA pulsatility (below 40%) and VMI (>0.45).
Other suggestive measures included pulmonary artery (PA) to
ascending aorta (AO) ratio (PA/AO). This ratio is an indirect mea-
sure of interventricular septal flattening during systole and corre-
lates with PASP [13]. Our meta-analysis reports higher results
than wang et al. and yielded a pooled sensitivity and specificity
of MRI as 0.92 and 0.86, respectively. Regardless of the measure-
ment used, MRI is found to be valuable in terms of prognosis and
follow up after treatment [14–16].
By contrast, TTE is the most convenient and initial noninvasive
screening tool. The including measurements of TTE for PH diagno-
sis and assessment include pulmonary artery regurgitant jet
method, measurement of the tricuspid annular plane systolic
excursion (TAPSE), two-dimensional strain tissue Doppler echocar-
diography, the speckle tracking method, acceleration time across
the pulmonic valve and the tricuspid regurgitant jet velocity
(TRV) [17–21]. TRV is used to calculate the ePASP using RAP, which
can be clinically estimated from jugular venous pressure (JVP)
using a fixed value of 10 mm Hg, and the diameter and collapse
of the inferior vena cava (IVC) during spontaneous respiration
[18,22–24]. ESC and ERS recommend using peak TRV alongside
other echocardiographic findings suggestive of PH such as right
ventricle/left ventricle basal diameter ratio > 1.0, right ventricular
outflow Doppler acceleration time < 105 ms and/or mid-systolic
notching & right atrial end-systole area > 18 cm2 [25]. Our review
Fig. 6. ROC demonstrating a higher sensitivity and specificity for CT compared to
RHC.
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showed that the study by Condliffe et al. used TRV to calculate the
tricuspid gradient (TG), while Collin et al. and Rajaram et. el. used
TR gradient (cut off of > 27 mmHg and>40) for diagnosing PH
[26–28]. Surrender et al., used sPAP as a measure of assessment
of PH with a cutoff range  30 mmHg [4]. The mPASP was calcu-
lated based on the maximum velocity of the tricuspid regurgitant
jet method (TRJ + RAP) (estimated using JVP/IVC collapse). Zhang
et al. included 6 studies, the measure used for the diagnosis of
PH was RVSP and PASP, demonstrating intermediate sensitivity
results compared to RHC [29]. A prior systematic review published
in 2010, assessed 29 studies, comparing TTE for screening and
diagnosis of PH. PASP measurement had a correlation of about
0.7 with RHC, with pooled sensitivity and specificity of 0.83 and
0.72, respectively [4]. Another meta-analysis examining two vari-
ables on CT, PA diameter and PA:A ratio was published by Shen
et al. in 2014. The reported sensitivities and specificities for the for-
mer was found to be 0.79 and 0.83, while for the later, it was 0.74
and 0.81, respectively [5]. Of note, PA diameter was also found to
correlate with prognosis in patients with chronic respiratory ill-
ness, e.g., bronchiectasis [6].
Fig. 7. Forest plot showing the individual and pooled sensitivity and specificity of TTE.
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On the contrary, our analysis included the largest population
from a total of 27 studies comparing TTE and RHC. Most included
studies used TRJ and RAP to calculate mPASP. Of the included stud-
ies, Opotowsky et al. used multiple parameters including RV dilata-
tion, prediction rule (ranges from 2 to + 2) and mid systolic notch
or acceleration time ＜80msec [30]. Single studies used right atrial
strain and RV free wall strain. Some studies were performed in
specific patient populations, such as patients with diffuse pul-
monary fibrosis, patients with systemic sclerosis, or liver trans-
plant candidates, which could result in a lack of generalizability
of results; however, this was a small minority of studies included
in ourmeta-analysis. Overall, our results showed a pooled sensitiv-
ity of 85% and specificity of 71% for TTE compared to RHC. Addi-
tionally, it is important to note that both TTE and CMR can be
useful to gauge response to therapy on regular follow-ups by
demonstrating reversal of right ventricular dilatation and change
in pulmonary vascular resistence.
The third noninvasive imaging modality used was CT scan,
which, compared to MRI, is feasible to obtain and can also give
information about the etiology of PH. The measure of diagnosis
on CT is main pulmonary artery diameter (MPAD) with a
cutoff > 29 mmwith a reported diagnostic sensitivity of 87%, speci-
ficity of 89%, and PPV of 97% [5,31]. The specificity of pH can reach
up to 100% with MPAD > 29 in combination with segmental artery–
to-bronchus diameter ratio of 1:1 in 3–4 lobes [32]. Other mea-
sures of diagnosis of PH on CT can be the main pulmonary artery
to ascending aorta diameter ratio of  1 [5,33,34]. CT scan also
helps to differentiate group-1 PH (secondary to lung disease and/
or hypoxia) from group-3 PH (Idiopathic, drug/toxin-induced, con-
nective tissue disease, and autoimmune cases) [15]. Shen et al.
reported a sensitivity of 79% and specificity of 83% based on the
pulmonary diameter and a sensitivity and specificity of 74% and
81% for TTE, respectively [5]. By contrast, our results included 27
studies comparing CT scan with RHC for diagnostic accuracy of
PH. Our results were in concordance with Shen et al. study, with
a sensitivity of 79% and specificity of 82% for both pulmonary
artery diameter and PA:A ratio. We think this is a valuable conclu-
sion as CT scans are readily available and done more frequently
than ever, mostly for reasons other than PH [35]. In addition, CT
scans can help in the diagnosis of concomitant lung parenchymal
diseases associated with higher pulmonary vascular resistance
(like bronchiectasis and interstitial lung disease). Furthermore,
other non-numerical surrogate indicators of cor pulmonale can
aid in the diagnosis of PH if seen by CT images (e.g: leftward septal
deviation and thickening of right ventricular free wall). [14]
Overall, we believe that both TTE and CT have been falling out of
favor in serially following patients diagnosed with PH due to oper-
ator dependency in the former and risk of radiation exposure in the
latter. MRI, however, has been shown to be exceptionally reliable
with good inter-study reproducibility in both healthy subjects
and patients with heart failure.[36]
5. Limitations
Though the data supports MRI being the most sensitive and
specific, further studies would need to be conducted to evaluate
the cost relationship between the three imaging modalities. Issues
such as the availability of the imaging modalities within different
health systems around the world, as well as having the appropriate
staff to read the imaging modality are required. A widespread vari-
ability in the measures and cutoffs of different parameters across
the included studies limited our ability to measure its predictive
effect. It is important to note that due to variable diagnostic
criterias used by the included studies, our results might fail to
identify a selected patient population who might have a normal
or near-normal PAP. Some articles used the RV remodeling as a
surrogate marker for PH, which could be misleading. Additionally,
we could not take into account the pre-test probability of PH and
could not include studies not reporting raw data of diagnostic
accuracy.
Fig. 8. ROC demonstrating a higher sensitivity and specificity for TTE compared to
RHC.
Table 1
Subgroup diagnostic accuracy of CT and TTE based on the inclusion criterias.
Criteria Imaging No. of studies Mean sensitivity Mean specificity
Pulmonary artery systolic pressure (PASP) TTE 12 0.78 0.68
Right ventricular systolic pressure (RVSP) TTE 6 0.88 0.62
Tricuspid regurgitant jet (TRJ) TTE 6 0.81 0.84
RV free wall strain TTE 1 0.92 0.45
Right ventricle diameter (RVd) TTE 2 0.79 0.77
Pulmonary artery diameter (PAd) CT 15 0.71 0.78
RV diameter CT 2 0.84 0.90
RV wall thickness CT 3 0.74 0.81
PA diameter/AA diameter CT 5 0.65 0.79
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6. Conclusions
MRI has the highest diagnostic accuracy among the noninvasive
diagnostic modalities for the detection of pulmonary hypertension.
Echocardiography is the most feasible test but has lower sensitivity
and specificity.
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